Lecanemab (BAN2401): an anti–beta-amyloid monoclonal antibody for the treatment of Alzheimer disease is a research paper published in Expert Opinion on Investigational Drugs (2023). On theSindex it has a DataRank of 0. It has been cited 118 times.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
NIA NIH HHS
Grant: P30 AG072980
NIA NIH HHS
Grant: R01 AG059008
NIA NIH HHS
Grant: R01 AG073212
FWCI
16.56
Citation Percentile
1.0%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals